Product Description: MGD010 is a bispecific CD32B (FcγRIIb) and CD79B antibody. MGD010 inhibits activated B-cells by delivering a negative signal via simultaneous co-ligation of CD32B (FcγRIIb), with the BCR component, CD79B. MGD010 has the potential for the study of autoimmune disorders[1].
Applications: COVID-19-immunoregulation
Formula: N/A
References: [1]Pandya, N., et al. OP0201 Safety, Tolerability, and Functional Activity of MGD010, A Dart® Molecule Targeting CD32B and CD79B, Following A Single Dose Administration in Healthy Volunteers. Annals of the Rheumatic Diseases, 2016. 75(Suppl 2), 132.3-133.
Molecular Weight: N/A
Research Area: Inflammation/Immunology
Target: Fc Receptor (FcR)